TSXV:CLAS.H - Post Discussion
Post by
Red~One on Apr 14, 2022 7:31pm
will now immediately begin enrollment
"April 5, 2022
SAN FRANCISCO, CA and TORONTO, ON — (April 5, 2022) – Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC: CLAZF) (the “Company” or “Claritas“) today announced that the Australian Human Research Ethics Committee has approved the Company’s submission for the Phase 1 clinical study of R-107 to be conducted at Scientia Clinical Research in Sydney, Australia. Claritas will now immediately begin enrollment in the study."
Where's the confirmation...."enrollment" is considerered part of the stage...."immediately" would mean as of April 5. So according to the NR CLAS is presently in Phase 1. Right?
Be the first to comment on this post